Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis
Evaluation of Evolution of Perceived Stress in General Practice Residents of Rouen and Caen During COVID-19 Sanitary Crisis
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Évreux, France, 27015
- CH Eure-Seine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Being a general practice resident in Rouen or Caen
- Participant informed and non-objection of him/her
Exclusion Criteria:
- Being on maternity leave or not working during the period concerned with the questionnaires
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evolution of perceived stress during the epidemic wave of COVID19 vs. at the end of the epidemic wave of COVID19
Time Frame: maximum 6 months, according to the evolution of the epidemic
|
The perceived stress will be evaluated using the Perceived Stress Scale.
This scale contains 10 items, with scores ranging from 0 to 40, with higher scores meaning a higher level of stress.
|
maximum 6 months, according to the evolution of the epidemic
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of general characteristics of residents and their feelings and experiences with the sanitary crisis
Time Frame: maximum 6 months, according to the evolution of the epidemic
|
This include socio-demographic characteristics, work-related information and potential stress factors
|
maximum 6 months, according to the evolution of the epidemic
|
|
Assessment of residents' profile stress according to their socio-demographic and working characteristics
Time Frame: maximum 6 months, according to the evolution of the epidemic
|
Identification of stress factors among residents
|
maximum 6 months, according to the evolution of the epidemic
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ségolène Guillemette, MD, General Practice Physician
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2020-A03283-36
- CHES N°20/01 (Other Identifier: CH Eure-Seine)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.